CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.

Cheng, Mangeng; Quail, Matthew R; Gingrich, Diane E; Ott, Gregory R; Lu, Lihui; Wan, Weihua; Albom, Mark S; Angeles, Thelma S; Aimone, Lisa D; Cristofani, Flavio; Machiorlatti, Rodolfo; Abele, Cristina; Ator, Mark A; Dorsey, Bruce D; Inghirami, Giorgio; Ruggeri, Bruce A.
Mol Cancer Ther; 11(3): 670-9, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22203728